ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
-1,31%
Dow Jones
41 433,48
-1,14%
DAX
22 328,77
-1,23%
Brent Oil
69,645
0,88%
Bitcoin
82 671,86
5,35%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) Actualités

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BNTC
DateHeureSourceTitreSymboleSociété
14/02/202514h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
14/02/202513h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
03/01/202523h39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
31/12/202412h34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
12/12/202400h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
14/11/202422h35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
13/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
01/11/202422h04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
23/10/202415h23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
15/10/202412h08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
11/10/202422h53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
01/10/202422h46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTCBenitec Biopharma Limited
26/09/202422h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
29/05/202422h32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BNTCBenitec Biopharma Limited
26/02/202415h06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
17/11/202314h00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
13/11/202314h00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
21/09/202314h00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
11/08/202319h00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
10/08/202322h06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
09/08/202304h30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
07/08/202314h11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
25/07/202319h00GlobeNewswire Inc.Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023NASDAQ:BNTCBenitec Biopharma Limited
07/07/202322h52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
26/06/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BNTCBenitec Biopharma Limited
26/06/202314h00GlobeNewswire Inc.Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNASDAQ:BNTCBenitec Biopharma Limited
15/06/202322h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202314h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202314h00GlobeNewswire Inc.Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
08/05/202314h05GlobeNewswire Inc.Benitec Biopharma to Present at the OPMD International ConferenceNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

Dernières Valeurs Consultées

NYSE
CFG
Citizens Financial
TSXV
FCLI
Full Circle Lithium
BIT
F37672
Vontobel Financial Produ...
CSE
JKS
JKS Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces